IRVINE, CA--(Marketwire - February 09, 2011) - ISTA Pharmaceuticals, Inc. (NASDAQ: ISTA) today announced it will release fourth quarter and full-year 2010 financial results after the market closes on February 23, 2011. In conjunction, the Company will host a conference call at 4:30 p.m. Eastern Time.
Date: Wednesday, February 23, 2011
Time: 4:30 p.m. Eastern Time
Conference call access:
Internet: www.istavision.com
Domestic dial-in: 866-770-7120
International dial-in: 617-213-8065
Passcode: 66872732
To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the replay is 11293297. This conference call also will be webcast live and archived on ISTA’s website until March 23, 2011.
About ISTA Pharmaceuticals
ISTA Pharmaceuticals, Inc., is the fourth largest and fastest growing branded prescription eye care business in the United States, with an expanding focus on allergy therapeutics. ISTA currently markets five products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The Company’s development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain and nasal allergies. Headquartered in Irvine, California, the Company generated 2009 revenues of $111 million. For additional information about ISTA Pharmaceuticals, please visit the corporate website at www.istavision.com.
Contacts
Investor Relations Contacts at ISTA Pharmaceuticals, Inc.:
Lauren Silvernail
949-788-5302
lsilvernail@istavision.com
Jeanie Herbert
949-789-3159
jherbert@istavision.com
Media and Additional Investor Relations Contacts at Burns McClellan:
Justin Jackson
(Media)
212-213-0006
jjackson@burnsmc.com
Juliane Snowden
(Investor Relations)
212-213-0006
jsnowden@burnsmc.com
